U.S. Biotech Stock News

If you are wondering whether Cboe Global Markets is still fairly priced after its strong run, this article will walk you through what the current share price might be implying. The stock recently closed at US$296.62, with returns of 5.8% over 7 days, a 0.9% decline over 30 days, 19.6% year to date, 45.7% over 1 year, 128.7% over 3 years, and 211.8% over 5 years. Recent headlines around Cboe Global Markets have kept attention on the stock, with news coverage focusing on its role in global...

NVR, Inc. recently faced cautious commentary as Seaport Global shifted its rating to “Sell” and multiple analysts highlighted risks ahead of the homebuilder’s upcoming fiscal first-quarter 2026 earnings release, including pressure on net income, margins, and cash flows. Amid these concerns, NVR is also contending with less favorable analyst rankings and valuation metrics than key peer D.R. Horton, sharpening investor focus on the company’s near-term competitive position. With the stock...

In late March and early April 2026, SoFi Technologies announced SoFi Big Business Banking, a unified fiat-and-crypto enterprise platform built on its regulated bank, and expanded its Loan Platform Business with over US$3.60 billion in new personal loan delivery commitments across three major partnerships. At the same time, SoFi came under pressure from a critical short seller report alleging aggressive accounting practices, which the company firmly denied while highlighting these new banking...

Wix.com (WIX) is back in focus after a cluster of analyst downgrades highlighted concerns around core growth, margins, valuation, and AI-driven competition, despite recent strength in bookings, revenue, Base44, and share repurchases. See our latest analysis for Wix.com. The recent cluster of downgrades has coincided with fading momentum. The share price has declined 8.14% over 1 day and the 1-year total shareholder return has declined 54.90%, despite earlier enthusiasm around earnings, Base44...

Eli Lilly (NYSE:LLY) agreed to acquire Centessa Pharmaceuticals for $7.8b, adding late stage sleep disorder therapies to its pipeline. The company secured $2.2b in manufacturing grant funding tied to a planned facility in Virginia. These moves come as Eli Lilly continues to rely heavily on its GLP-1 obesity and diabetes drugs while expanding into new treatment areas. Eli Lilly’s share price sits around $953.3, after a 27.4% gain over the past year and a 5-year return of 447.6%. The stock...

Steel Dynamics, Inc. recently announced that longtime directors Richard P. Teets, Jr. and Gabriel L. Shaheen will retire from its Board at the end of their current terms, effective after the 2026 Annual Meeting of Shareholders on May 6, 2026. The leadership transition comes just weeks before the company’s anticipated fiscal first-quarter 2026 earnings release, which analysts expect to show very strong year-over-year profit growth driven by firmer steel prices and healthy demand. We’ll now...

Tetra Tech (NasdaqGS:TTEK) has appointed Eric W. Thornburg, a veteran water industry leader, to its Board of Directors. Thornburg brings more than 40 years of leadership experience across major water utilities to the company. The appointment reflects Tetra Tech's focus on deepening its expertise in water, a core area for its clients. Tetra Tech focuses on consulting and engineering services, with water projects at the center of its client offering. For investors watching the broader water...

Coeur Mining has reported early participation results for its private exchange offer, with Eligible Holders tendering US$385,300,000 of New Gold’s US$400,000,000 6.875% Senior Notes due 2032 and consenting to remove many restrictive covenants and certain events of default from the existing indenture. This high early take-up signals broad bondholder support for Coeur’s capital structure plans, potentially giving the company greater flexibility in how it manages its balance sheet and future...

Anbio Biotechnology (ANBF) has reported its FY 2025 results, with first half revenue of US$4.6 million and basic EPS of US$0.09. This is set against a trailing twelve month revenue base of US$8.6 million and EPS of US$0.15 that is linked to a 169.9% earnings increase over the past year. Over recent periods the company has seen revenue move from US$5.8 million in 1H 2024 to US$2.3 million in 2H 2024 and then to US$4.6 million in 1H 2025, while net income shifted from US$3.6 million to a US$1.2...

Alibaba Group Holding (NYSE:BABA) has launched a new AI focused data center in partnership with China Telecom, powered by its in house Zhenwu semiconductors. The company has also formed a technology council aimed at speeding up decisions on AI infrastructure and long term technology priorities. These moves arrive as China targets more self sufficiency in critical tech, while global chip access remains affected by ongoing US restrictions. For you as an investor, this development sits at the...

Wondering whether Bread Financial Holdings at around US$78.65 is offering real value or just looks interesting on the surface? This article breaks down what the current share price might be implying. The stock has posted returns of 6.9% over the last week, 8.5% over 30 days, 4.4% year to date and 65.3% over the past year, with a 3 year return of 205.5% and flat performance over 5 years. Recent headlines have focused on Bread Financial Holdings as a US consumer finance player in the credit...

Why Confluent (CFLT) is in focus now Confluent (CFLT) is back in the spotlight after disclosing reduced cloud usage from a major AI native customer and facing an investor investigation into possible securities law violations and related business conduct. See our latest analysis for Confluent. After the disclosure about reduced cloud usage and the legal probe, investors have already experienced some volatility, yet Confluent’s 16.94% 1 year total shareholder return and 48.99% 3 year total...

Wondering if Corteva at around US$83.96 is priced for opportunity or already fully valued? This article walks through the key signals that can help you judge that for yourself. The stock has returned 0.2% over the past week, 7.2% over 30 days, 23.9% year to date, and 44.8% over the last year, which naturally raises questions about what is already baked into the price. Recent attention on Corteva has focused on its position within the broader materials and agriculture space and how investors...

In early April 2026, Shift4 Payments’ board declared a US$1.50 per share cash dividend on 10,000,000 shares of its 6% Series A Mandatory Convertible Preferred Stock, payable on May 1, 2026 to holders of record on April 15, 2026. This capital return to preferred holders arrives as analysts have recently raised near-term earnings estimates and highlighted Shift4’s pattern of outperforming forecasts, sharpening focus on the company’s upcoming results. We’ll now examine how rising analyst...

RPM International (RPM) just posted Q3 2026 results with revenue of US$1.6b and basic EPS of US$0.40, alongside net income excluding extra items of US$51.4m, putting fresh numbers around a year that also includes trailing 12 month revenue of US$7.7b and EPS of US$5.21. Over the past few quarters, the company has seen revenue move from US$1.48b in Q3 2025 to US$2.11b in Q1 2026 before landing at US$1.61b in the latest quarter. Basic EPS has ranged from around US$0.41 to US$1.78 across that...

Williams Companies disclosed that on March 23, 2026, Executive Board Chair and director Alan S. Armstrong resigned from the Board to accept a United States Senate appointment, with former Chairman and Independent Lead Director Stephen W. Bergstrom re-elected as Chairman and the Board size reduced from 12 to 11 members. This shift removes a long-standing executive voice from both the chair and Environmental, Health and Safety Committee roles, placing more emphasis on how Bergstrom and the...

If you are wondering whether Hewlett Packard Enterprise at around US$24.98 is still offering value or if most of the upside has already been captured, the starting point is to understand what the current price actually reflects. The stock has shown strong returns over several time frames, with 4.2% over the last 7 days, 14.5% over the last 30 days, 3.4% year to date, 76.6% over the past year, 69.6% over 3 years and 83.2% over 5 years. Recent headlines have focused on Hewlett Packard...

In early April 2026, EQT, the largest U.S. natural gas producer, completed a US$1.40 billion debt tender offer to strengthen its balance sheet, even as energy stocks broadly weakened following easing U.S.-Iran tensions and lower crude prices. At the same time, EQT’s strong recent cash generation, improving margins, legal win in Pennsylvania, and upcoming earnings announcement are sharpening the contrast between company-specific progress and wider energy sector pressures. We’ll now examine...

Why Griffon’s joint venture is in focus now Griffon (GFF) is drawing fresh attention after agreeing to combine its AMES Companies with ONCAP’s Venanpri Tools brands. This move shifts the group toward a pure play North American building products focus. See our latest analysis for Griffon. The joint venture news has arrived as Griffon’s 1-day share price return of 4.74% and 7-day share price return of 3.47% contrast with a slightly negative 90-day share price return of 2.36%. At the same time,...

Take-Two Interactive Software: Recent Returns Put Valuation in Focus Take-Two Interactive Software (TTWO) has drawn fresh investor attention after a mixed stretch of returns, with the stock roughly flat over the past year but showing a loss of about 20% in the past 3 months. See our latest analysis for Take-Two Interactive Software. With the share price at $202.13, the recent 90 day share price return of about a 20% decline contrasts with a far stronger 3 year total shareholder return of...

Why Chubb Stock Is On Investors’ Radar Chubb (CB) is drawing fresh attention after recent share price moves, with the stock closing at $332.64 and showing positive returns over the past week, month, and past 3 months. See our latest analysis for Chubb. For context, recent gains sit within a broader upswing, with a 1-year total shareholder return of 18.39% and a 3-year total shareholder return of 74.09%, suggesting momentum has been building rather than fading. If Chubb’s move has caught your...

In early April 2026, Citigroup downgraded Bio-Rad Laboratories’ rating from “Buy” to “Neutral,” signaling a shift in analyst sentiment toward the life science and clinical diagnostics company. This reassessment comes as Bio-Rad is cited among key players in the rapidly expanding single-cell omics market, where demand for advanced tools in cancer, immunology, and stem cell research is intensifying. We’ll now examine how Citigroup’s downgrade, against a backdrop of growing single-cell omics...

Mastercard (MA) heads into its upcoming earnings report with growing investor optimism, as analyst expectations point to year over year gains in both earnings per share and revenue, supported by recent upward estimate revisions. See our latest analysis for Mastercard. At a share price of US$507.12, Mastercard’s 1 day share price return of 1.77% and 7 day share price return of 3.15% sit against a softer 90 day share price return of 12.58% and a 1 year total shareholder return of 1.03%. This...

If you are wondering whether StoneX Group's current share price reflects its real worth, the recent trading history gives you plenty to think about. The stock last closed at US$91.62, with returns of 13.4% over 7 days, 26.0% over 30 days, 41.1% year to date, 80.3% over 1 year, 204.9% over 3 years, and 372.3% over 5 years. Recent headlines have focused on StoneX Group as a diversified financial services provider operating across capital markets and related services. This helps explain why...